HEM
PJP icon

Henson-Edgewater Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Henson-Edgewater Management’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$271K Sell
2,170
-275
-11% -$29.8K 0.14% 54
2026
Q1 		$254K Hold
2,445
– – 0.16% 57
2025
Q4 		$256K Buy
+2,445
New +$246K 0.15% 59

Other funds holding PJP

PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
JGCM
Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Henson-Edgewater Management's PJP Position: Q2 2026 in Review

Henson-Edgewater Management reduced its Invesco Pharmaceuticals ETF (PJP) stake by 11% in Q2 2026, selling an estimated $29.8K and leaving 2,170 shares worth $271K. The position accounts for 0.14% of the portfolio, ranked #54.

Henson-Edgewater Management first reported a position in PJP in Q4 2025 and has held it in 3 quarters since. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

  • Henson-Edgewater Management held 2,170 shares of Invesco Pharmaceuticals ETF worth $271K as of Q2 2026.
  • Henson-Edgewater Management sold 275 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $29.8K.
  • Invesco Pharmaceuticals ETF made up 0.14% of Henson-Edgewater Management's portfolio in Q2 2026, its #54 holding.
  • Henson-Edgewater Management first reported a position in Invesco Pharmaceuticals ETF in Q4 2025 and has held it in 3 quarters since.
  • 117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Henson-Edgewater Management's 13F filing for Q2 2026, filed 18 Aug 2026.